Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Ordinary Shares, $0.01 par value per share
-
Shares outstanding
-
28,961,082
-
Total 13F shares
-
2,279,287
-
Share change
-
+1,252,367
-
Total reported value
-
$2,267,892
-
Price per share
-
$1.00
-
Number of holders
-
18
-
Value change
-
+$1,239,830
-
Number of buys
-
8
-
Number of sells
-
3
Institutional Holders of Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM) as of Q2 2025
As of 30 Jun 2025,
Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,279,287 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, Squarepoint Ops LLC, SABBY MANAGEMENT, LLC, New Leaf Venture Partners, L.L.C., Apollon Financial, LLC, OneDigital Investment Advisors LLC, JANE STREET GROUP, LLC, TWO SIGMA INVESTMENTS, LP, Sanctuary Advisors, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
19
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.